Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì
  #46  
Ñòàðûé 12.02.2011, 16:44
NPV NPV âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 18.01.2011
Ãîðîä: Íÿãàíü
Ñîîáùåíèé: 12
Ñêàçàë(à) ñïàñèáî: 18
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
NPV *
Ïðî âðåìÿ ñêîïèè è äîçó íàïèøó ïîçæå, à òî ñåé÷àñ óæå âûøåë èç "îïåðû". Î÷åðåäíîé ÎÊÑ ñ ïîäúåìîì. ×òî-òî êàæäûé äåíü îíè ó íàñ. Âîäû â âåíó ëüåì äîñòàòî÷íî. Åñëè ïàöèåíò "íå äåðæèò ïóçûðü" - êàòåòåð åìó òóäà. È ïëþñ ðåîëîãè÷åñêèå ñìåñè. Ãåìîõåñ, âîëþâåí è ïð. Íî ñóììàðíî äî 2 ëèòðîâ íà äëèòåëüíóþ ïðîöåäóðó. À ñîäû ó íàñ â "êëèíèêå" âîîáùå íåò, êóäà-òî ïîäåâàëàñü... À âîò è èíñóëüò ïðèâåçëè èøåìè÷åñêèé... Óøåë îïÿòü ðàáîòàòü.
Îòâåòèòü ñ öèòèðîâàíèåì
  #47  
Ñòàðûé 12.02.2011, 23:01
Àâàòàð äëÿ angio
angio angio âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 27.04.2010
Ãîðîä: Ïåòðîçàâîäñê
Ñîîáùåíèé: 949
Ñêàçàë(à) ñïàñèáî: 36
Ïîáëàãîäàðèëè 115 ðàç(à) çà 106 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 1
angio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íà ñ÷åò íåôðîïàòèè ïîçâîëþ ñåáå ïðîöèòèðîâàòü:

Öèòàòà:
Ñîîáùåíèå îò dmblok Ïîñìîòðåòü ñîîáùåíèå
ACT: No benefit of N-acetylcysteine to reduce contrast-induced nephropathy

Chicago, IL - The addition of N-acetylcysteine failed to reduce the risk of contrast-induced nephropathy in patients undergoing coronary and vascular angiography. The findings, from the Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT), the largest randomized study to date, provide solid evidence that N-acetylcysteine is not effective in this setting and should no longer be used for the prevention of contrast-induced nephropathy, according to investigators.
"I would be comfortable saying that this is a definitive trial, and I'd be comfortable saying that because if you look at the other high-quality trials, we reached exactly the same result," Dr Otavio Berwanger (Hospital do Coração, São Paulo, Brazil) told heartwire. "It would be extremely unlikely that another trial would be conducted, say a larger 20 000-patient trial, and would find a different result. One thing that is interesting with negative trials is that there is often a subgroup, maybe sicker patients, the elderly, that might have a different result. But here, it was very consistent."
Presenting the results of the study today during the late-breaking clinical-trials session here at the American Heart Association (AHA) 2010 Scientific Sessions, Berwanger explained that N-acetylcysteine, an antioxidant, has been used as adjunctive therapy for about 10 years to reduce kidney injury caused by contrast used in coronary and vascular angiography. Despite its use, however, the evidence accumulated to date is conflicting, leaving questions about its role in clinical practice.
In ACT, investigators randomized 2308 patients undergoing an angiographic procedure to 1200 mg of N-acetylcysteine, prescribed orally twice daily, with two doses given before the procedure and two doses after the procedure, or to placebo.

Despite treatment with N-acetylcysteine, they observed "absolutely no difference" in the primary end point of contrast-induced nephropathy and no difference in the secondary end point of serum creatinine elevations. Similarly, 30-day clinical end points, including mortality, the need for dialysis, or cardiovascular mortality, were no different between placebo- and N-acetylcysteine-treated patients. A subgroup analysis revealed no benefit in any patient population, including patients stratified by age, the presence of diabetes mellitus, sex, serum creatinine levels, or type of contrast used prior to angiography.

Berwanger and colleagues also performed their own meta-analysis, looking only at other high-quality studies, and observed no reduction in risk with N-acetylcysteine. Those results, Berwanger told heartwire, are in line with the lack of benefit observed in ACT.
Îòâåòèòü ñ öèòèðîâàíèåì
  #48  
Ñòàðûé 12.02.2011, 23:44
Àâàòàð äëÿ thorn
thorn thorn âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.04.2003
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 782
Ïîáëàãîäàðèëè 15 ðàç(à) çà 15 ñîîáùåíèé
thorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ýýý...âîïðîñ òàêîé...ïðè íàëè÷èè ñòåíîçà/îêêëþçèè âåíîçíîãî øóíòà ïðàâèëüíî ñíà÷àëà ïûòàòüñÿ îòêðûâàòü øóíò èëè íàòèâíóþ àðòåðèþ?
Îòâåòèòü ñ öèòèðîâàíèåì
  #49  
Ñòàðûé 13.02.2011, 10:03
Àâàòàð äëÿ avderb
avderb avderb âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 20.01.2011
Ãîðîä: Ïåòðîçàâîäñê
Ñîîáùåíèé: 20
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
avderb ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò thorn Ïîñìîòðåòü ñîîáùåíèå
Ýýý...âîïðîñ òàêîé...ïðè íàëè÷èè ñòåíîçà/îêêëþçèè âåíîçíîãî øóíòà ïðàâèëüíî ñíà÷àëà ïûòàòüñÿ îòêðûâàòü øóíò èëè íàòèâíóþ àðòåðèþ?
Èç ëè÷íûõ íàáëþäåíèé çà ðàáîòîé êîëëåãè Jean Fajadet: ïðè îêêëþçèè ÌÊØ âìåøàòåëüñòâî íà íàòèâíîé àðòåðèè, ïðè ñòåíîçå - ñòåíòèðîâàíèå øóíòà áåç ëèøíèõ òåëîäâèæåíèé (èëè ñ ëîâóøêîé), äàáû "íå íàêðîøèòü" â äèñòàëüíîå ðóñëî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #50  
Ñòàðûé 13.02.2011, 10:37
Àâàòàð äëÿ audovichenko
audovichenko audovichenko âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 26.01.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 7,477
Ïîáëàãîäàðèëè 1,531 ðàç(à) çà 1,497 ñîîáùåíèé
audovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò thorn
âîïðîñ òàêîé...ïðè íàëè÷èè ñòåíîçà/îêêëþçèè âåíîçíîãî øóíòà ïðàâèëüíî ñíà÷àëà ïûòàòüñÿ îòêðûâàòü øóíò èëè íàòèâíóþ àðòåðèþ?
Îêêëþçèðîâàííûå âåíîçíûå øóíòû îòêðûâàòü íå íóæíî - âðåäà áîëüøå, ÷åì ïîëüçû.
Ñòåíîçû, êàê ïðàâèëî, ìîæíî ñòåíòèðîâàòü. Âïðî÷åì, åñëè ïðîéòè â íàòèâíîå ðóñëî ïðîùå - èìååò ñìûñë ñòåíòèðîâàòü íàòèâíîå ðóñëî.  îáùåì, ýòî ðåøàåòñÿ èíäèâèäóàëüíî ïî ðåçóëüòàòàì ÊÃ-ØÃ.

Êîììåíòàðèè ê ñîîáùåíèþ:
Abugov îäîáðèë(à): Íàäî ñòàðàòüñÿ âîññòàíàâëèâàòü íàòèâíîå ðóñëî
thorn îäîáðèë(à): ñïàñèá
Îòâåòèòü ñ öèòèðîâàíèåì
  #51  
Ñòàðûé 19.02.2011, 10:07
Àâàòàð äëÿ shok
shok shok âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 02.11.2010
Ãîðîä: Rus.
Ñîîáùåíèé: 759
Ñêàçàë(à) ñïàñèáî: 39
Ïîáëàãîäàðèëè 38 ðàç(à) çà 37 ñîîáùåíèé
shok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
"ðàáî÷àÿ ëîøàäêà" äëÿ ÎÊÑ?

Êîëëåãè, ðàññêàæèòå, ïæñòà, êòî ÷òî ïîëüçóåò äëÿ ÎÊÑ - ñòàíäàðòíûé ðàáî÷èé BMS - êàêîé???
Îòâåòèòü ñ öèòèðîâàíèåì
  #52  
Ñòàðûé 19.02.2011, 11:19
Proxor Proxor âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 03.05.2008
Ãîðîä: ã. Õàíòû-Ìàíñèéñê
Ñîîáùåíèé: 90
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 13 ðàç(à) çà 12 ñîîáùåíèé
Proxor ýòîò ó÷àñòíèê èìååò îòëè÷íóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò shok Ïîñìîòðåòü ñîîáùåíèå
Êîëëåãè, ðàññêàæèòå, ïæñòà, êòî ÷òî ïîëüçóåò äëÿ ÎÊÑ - ñòàíäàðòíûé ðàáî÷èé BMS - êàêîé???
Ó íàñ ïîêà ïîä ðóêîé SatinFlex, Genous, Presillion.
Îòâåòèòü ñ öèòèðîâàíèåì
  #53  
Ñòàðûé 20.02.2011, 06:52
Àâàòàð äëÿ shok
shok shok âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 02.11.2010
Ãîðîä: Rus.
Ñîîáùåíèé: 759
Ñêàçàë(à) ñïàñèáî: 39
Ïîáëàãîäàðèëè 38 ðàç(à) çà 37 ñîîáùåíèé
shok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
àëëåðãèÿ íà éîä

â÷åðà èíòåðåñíûé ñëó÷àé: æåíùèíà, îêñ ñ ïST, áîëåé íåò. â ïðèíöèïå, ïîêàçàíà ÊÀà ñ ×ÊÂ, íî! îíà ãîâîðèò, ÷òî ó íåå àëëåðãèÿ íà éîä. ÷òî êîãäà-òî ÷òî-òî ìàçàëà éîäîì, áûëî ïîêðàñíåíèå ëèöà, ïðèïóõëîñòü è îòåêè... âçÿëè îáû÷íûé éîä, "ïîìàçàëè" åé ó÷àñòîê ïðåäïëå÷üÿ - íèêàêîé îñîáîé ðåàêöèè...
âîïðîñ âîò â ÷åì, åñëè ïàöèåíò óòâåðæäàåò, ÷òî ó íåãî àëëåðãèÿ íà éîä, ìîæåì ëè ìû åãî áðàòü â êàòëàá è ââîäèòü êîíòðàñò? ñ îäíîé ñòîðîíû, íà ñîâð. êîíòðàñòû ðåàêöèé è íå áûâàåò (ïî÷òè), ñ äðóãîé ñòîðîíû, åñëè áóäåò àíàôèëàêò. øîê ó òàêîãî ïàöèåíòà, äà åùå â ÈÁ åñòü çàïèñü, ÷òî ïàöèåíò óêàçûâàë íà àëëåðãèþ...
Îòâåòèòü ñ öèòèðîâàíèåì
  #54  
Ñòàðûé 20.02.2011, 10:01
Lev74 Lev74 âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 18.08.2010
Ãîðîä: Óôà
Ñîîáùåíèé: 97
Ñêàçàë(à) ñïàñèáî: 23
Ïîáëàãîäàðèëè 7 ðàç(à) çà 7 ñîîáùåíèé
Lev74 ýòîò ó÷àñòíèê èìååò îòëè÷íóþ ðåïóòàöèþ íà ôîðóìå
Éîä - ýòî åñòåñòâåííûé ìèêðîýëåìåíò. Éîä ïðèñóòñòâóåò âñåãäà â îðãàíèçìå ëþáîãî æèâîãî ÷åëîâåêà. Òåðìèí " àëëåðãèÿ èìåííî íà Éîä" ñ÷èòàþ íåïðàâîìî÷íûì.  íà÷àëå 2002 ãîäà Ñåðãåé Àëåêñàíäðîâè÷ íàñ ó÷èë, ÷òî àëëåðãè÷åñêèå ðåàêöèè (òÿæåëûå â âèäå àíàôèëàêòè÷åñêîãî øîêà) íà èîííûå êîíòðàñòíûå ïðåïàðàòû ñëó÷àþòñÿ ñ ÷àñòîòîé 4-5 íà òûñÿ÷ó ïàöèåíòîâ, à íà íåèîííûå ñ ÷àñòîòîé 1 íà 4000-5000 ïàöèåíòîâ. Çà äåñÿòü ëåò ðàáîòû àëëåðãèè íà íåèîííûå ïðåïàðàòû íå âèäåë (ðàáîòàåì Óëüòðàâèñòîì è Îìíèïàêîì).
Ïðè ïðèíÿòèè ðåøåíèÿ î ïðîâåäåíèè ïðîöåäóðû âñåãäà âçâåøèâàåòñÿ ðèñê è âîçìîæíàÿ ïîëüçà. Åñëè ïðîöåäóðà ïî æèçíåííûì ïîêàçàíèÿì, òî è îòíîøåíèå ê ðèñêàì ñîîòâåòñòâóþùåå.
Êàêèå ëèáî ïðîáû çà ñóòêè äâîå äî ïðîöåäóðû (òèïà Áåçðåäêè) íà ñåãîäíÿ ïðèçíàíû íåýôôåêòèâíûìè, òàê êàê ñàìè ìîãóò áûòü ïðè÷èíîé ñåíñèáèëèçàöèè.
Ïàöèåíòîâ ñ âûñîêèì ðèñêîì ïî àëëåðãè÷åñêèì ðåàêöèÿì ìîæíî ðàçäåëèòü íà äâå ãðóïïû: ïåðâûå ãîâîðÿò, ÷òî ó íèõ áûëè îæîãè ïðè êîíòàêòå ñ Éîäîì, âòîðûå ÷òî ó íèõ áûëè ðåàêöèè òèïà êðàïèâíèöû íà ðàíåå ââîäèìûå êîíòðàñòíûå ïðåïàðàòû. Âòîðûõ ñ÷èòàåì îïàñíåå è áåðåì òîëüêî â î÷åíü êðàéíåì ñëó÷àå. Ñ ïåðâûìè ÷óâñòâóåì ñåáÿ ñâîáîäíåå. Äëÿ ñîáñòâåííîé ïñèõîëîãè÷åñêîé ïîääåðæêè çà ïîë÷àñà äî ïðîöåäóðû âûïîëíÿåì ñêàðèôèêàöèîííóþ ïðîáó (öàðàïèíà íà ïðåäïëå÷üå è êàïëÿ êîíòðàñòà).  ïðîöåññå ïðîöåäóðû îáÿçàòåëüíî êàòåòåðèçàöèÿ öåíòðàëüíîé âåíû. Õîðîøåå àíòèãèòàìèííîå ïðèêðûòèå è àíåñòåçèîëîã â ïîëîæåíèè íèçêîãî ñòàðòà...
Ïîêà Áîã ìèëîâàë...
Îòâåòèòü ñ öèòèðîâàíèåì
  #55  
Ñòàðûé 20.02.2011, 10:03
rsp rsp âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 17.12.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 686
Ïîáëàãîäàðèëè 58 ðàç(à) çà 51 ñîîáùåíèé
rsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò shok Ïîñìîòðåòü ñîîáùåíèå
â÷åðà èíòåðåñíûé ñëó÷àé: æåíùèíà, îêñ ñ ïST, áîëåé íåò. â ïðèíöèïå, ïîêàçàíà ÊÀà ñ ×ÊÂ, íî! îíà ãîâîðèò, ÷òî ó íåå àëëåðãèÿ íà éîä. ÷òî êîãäà-òî ÷òî-òî ìàçàëà éîäîì, áûëî ïîêðàñíåíèå ëèöà, ïðèïóõëîñòü è îòåêè... âçÿëè îáû÷íûé éîä, "ïîìàçàëè" åé ó÷àñòîê ïðåäïëå÷üÿ - íèêàêîé îñîáîé ðåàêöèè...
âîïðîñ âîò â ÷åì, åñëè ïàöèåíò óòâåðæäàåò, ÷òî ó íåãî àëëåðãèÿ íà éîä, ìîæåì ëè ìû åãî áðàòü â êàòëàá è ââîäèòü êîíòðàñò? ñ îäíîé ñòîðîíû, íà ñîâð. êîíòðàñòû ðåàêöèé è íå áûâàåò (ïî÷òè), ñ äðóãîé ñòîðîíû, åñëè áóäåò àíàôèëàêò. øîê ó òàêîãî ïàöèåíòà, äà åùå â ÈÁ åñòü çàïèñü, ÷òî ïàöèåíò óêàçûâàë íà àëëåðãèþ...
Ñëó÷àé â ïðèíöèïå áàíàëüíûé, âñå îòâåòû ìîæíî íàéòè çäåñü: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
Abugov îäîáðèë(à):
shok îäîáðèë(à): ñïàñèáî
Îòâåòèòü ñ öèòèðîâàíèåì
  #56  
Ñòàðûé 20.02.2011, 10:04
Lev74 Lev74 âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 18.08.2010
Ãîðîä: Óôà
Ñîîáùåíèé: 97
Ñêàçàë(à) ñïàñèáî: 23
Ïîáëàãîäàðèëè 7 ðàç(à) çà 7 ñîîáùåíèé
Lev74 ýòîò ó÷àñòíèê èìååò îòëè÷íóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò shok Ïîñìîòðåòü ñîîáùåíèå
Êîëëåãè, ðàññêàæèòå, ïæñòà, êòî ÷òî ïîëüçóåò äëÿ ÎÊÑ - ñòàíäàðòíûé ðàáî÷èé BMS - êàêîé???
 îñíîâíîì Gazelle, åñëè ñèëüíî êðèâî Driver.
Îòâåòèòü ñ öèòèðîâàíèåì
  #57  
Ñòàðûé 20.02.2011, 22:16
Susanin Susanin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 17.09.2007
Ãîðîä: Bad Segeberg, Ãåðìàíèÿ
Ñîîáùåíèé: 370
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 50 ðàç(à) çà 50 ñîîáùåíèé
Susanin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSusanin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSusanin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSusanin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSusanin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSusanin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSusanin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSusanin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
À âìåñòî Driver ðàçâå íå ïîøåë åùå Integrity?

Êîëëåãè, ñêàæèòå ïîæàëóéñòà, êòî ÍÅ îòíîñèòñÿ ê ñòåíòó Genous êàê ê îáû÷íîìó BMS?
Îòâåòèòü ñ öèòèðîâàíèåì
  #58  
Ñòàðûé 21.02.2011, 07:52
Àâàòàð äëÿ Abugov
Abugov Abugov âíå ôîðóìà
Ðåíòãåíîõèðóðã
      
 
Ðåãèñòðàöèÿ: 20.02.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,178
Ïîáëàãîäàðèëè 202 ðàç(à) çà 197 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 2
Abugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Lev74 Ïîñìîòðåòü ñîîáùåíèå
Éîä - ýòî åñòåñòâåííûé ìèêðîýëåìåíò. Éîä ïðèñóòñòâóåò âñåãäà â îðãàíèçìå ëþáîãî æèâîãî ÷åëîâåêà. Òåðìèí " àëëåðãèÿ èìåííî íà Éîä" ñ÷èòàþ íåïðàâîìî÷íûì.
Ïîëíîñòüþ ñîãëàñåí. Àëëåðãèÿ íà éîä áûâàåò, íî íåëüçÿ ñòàâèòü çíàê ðàâåíñòâà ñ àëëåðãèåé íà ÊÂ. Õîòÿ, êîíå÷íî, ðèñê àëëåðãèè íà Ê ó á-õ ñ àëëåðãèåé íà éîä âûøå. Âïðî÷åì, êàê è ïðè ëþáîé äðóãîé àëëåðãèè.
Öèòàòà:
Ñîîáùåíèå îò Lev74 Ïîñìîòðåòü ñîîáùåíèå
Çà äåñÿòü ëåò ðàáîòû àëëåðãèè íà íåèîííûå ïðåïàðàòû íå âèäåë (ðàáîòàåì Óëüòðàâèñòîì è Îìíèïàêîì).
À âîò ýòî ïîòðÿñëî îñíîâû ìîåãî ìèðîâîñïðèÿòèÿ. Âîîáùå íè îäíîé àëëåðãèè? Ìû èõ âèäèì íåñêîëüêî â íåäåëþ.

Öèòàòà:
Ñîîáùåíèå îò Lev74 Ïîñìîòðåòü ñîîáùåíèå
Ïàöèåíòîâ ñ âûñîêèì ðèñêîì ïî àëëåðãè÷åñêèì ðåàêöèÿì ìîæíî ðàçäåëèòü íà äâå ãðóïïû: ïåðâûå ãîâîðÿò, ÷òî ó íèõ áûëè îæîãè ïðè êîíòàêòå ñ Éîäîì, âòîðûå ÷òî ó íèõ áûëè ðåàêöèè òèïà êðàïèâíèöû íà ðàíåå ââîäèìûå êîíòðàñòíûå ïðåïàðàòû. Âòîðûõ ñ÷èòàåì îïàñíåå è áåðåì òîëüêî â î÷åíü êðàéíåì ñëó÷àå. Ñ ïåðâûìè ÷óâñòâóåì ñåáÿ ñâîáîäíåå. Äëÿ ñîáñòâåííîé ïñèõîëîãè÷åñêîé ïîääåðæêè çà ïîë÷àñà äî ïðîöåäóðû âûïîëíÿåì ñêàðèôèêàöèîííóþ ïðîáó (öàðàïèíà íà ïðåäïëå÷üå è êàïëÿ êîíòðàñòà).  ïðîöåññå ïðîöåäóðû îáÿçàòåëüíî êàòåòåðèçàöèÿ öåíòðàëüíîé âåíû. Õîðîøåå àíòèãèòàìèííîå ïðèêðûòèå è àíåñòåçèîëîã â ïîëîæåíèè íèçêîãî ñòàðòà...
Ïîêà Áîã ìèëîâàë...
Ëþáîé áîëüíîé ñ èñòîðèåé àëëåðãèè ìîæåò áûòü ïîäâåðãíóò êàòåòåðèçàöèè (åñëè ýòî äåéñòâèòåëüíî íåîáõîäèìî). ÐÑÏ çäåñü ïðèâ¸ë ãàéäû, êîòîðûå ìû ïðèìåíÿåì áåñïðåêîñëîâíî. Ãîðìîíû çà 13, 7 è 1 ÷àñ äî ïðîöåäóðû. Íåîáõîäèìîñòè â ñêàðèôèêàöèîííîé ïðîáå ÿ íå âèæó. À âîò âåíà è àíåñòåçèîëîã - ôîðåâà. Âïðî÷åì, ó âñåõ íàøèõ á-õ åñòü âåíà è àíåñòåçèîëîã. È, ïîçâîëþ ñåáå çàìåòèòü, ÷òî ó íåèîííûõ Ê áûâàåò î÷åíü îòñðî÷åííîå ïðîÿâëåíèå àëëåðãèè - áîëåå ñóòîê. Òàê ÷òî, çà áîëüíûìè íàäî âíèìàòåëüíî íàáëþäàòü ìèíèìóì 48 ÷àñîâ.
Áîëüíîé ñ ïîäú¸ìîì ST - îñîáûé ñëó÷àé. Åãî íàäî êàòåòåðèçèðîâàòü, íåñìîòðÿ íè íà ÷òî. È óæ àëëåðãèÿ ÿâëÿåòñÿ íàèìåíüøåé èç ïðîáëåì â ñîâðåìåííîì ìèðå.
Ïðîøó ïðîùåíèÿ çà íåêîòîðóþ èçëèøíþþ äèäàêòè÷íîñòü ïîñòà.
__________________
Àáóãîâ Ñåðãåé Àëåêñàíäðîâè÷.
Ðîññèéñêèé Íàó÷íûé Öåíòð Õèðóðãèè èì. àêàäåìèêà Á.Â. Ïåòðîâñêîãî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #59  
Ñòàðûé 21.02.2011, 08:31
Àâàòàð äëÿ shok
shok shok âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 02.11.2010
Ãîðîä: Rus.
Ñîîáùåíèé: 759
Ñêàçàë(à) ñïàñèáî: 39
Ïîáëàãîäàðèëè 38 ðàç(à) çà 37 ñîîáùåíèé
shok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåshok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Susanin Ïîñìîòðåòü ñîîáùåíèå
Êîëëåãè, ñêàæèòå ïîæàëóéñòà, êòî ÍÅ îòíîñèòñÿ ê ñòåíòó Genous êàê ê îáû÷íîìó BMS?
Âû èìååòå ââèäó åãî áèîèíæåíåðíîñòü?
Îòâåòèòü ñ öèòèðîâàíèåì
  #60  
Ñòàðûé 21.02.2011, 19:42
NPV NPV âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 18.01.2011
Ãîðîä: Íÿãàíü
Ñîîáùåíèé: 12
Ñêàçàë(à) ñïàñèáî: 18
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
NPV *
Öèòàòà:
Ñîîáùåíèå îò shok Ïîñìîòðåòü ñîîáùåíèå
Êîëëåãè, ðàññêàæèòå, ïæñòà, êòî ÷òî ïîëüçóåò äëÿ ÎÊÑ - ñòàíäàðòíûé ðàáî÷èé BMS - êàêîé???
Çäðàâñòâóéòå, Shok! Ó íàñ Abbott "Multi-Link Vision" è Rontis "Leader Plus". Ïîêà íå æàëóåìñÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò


Îïöèè òåìû Ïîèñê â ýòîé òåìå
Ïîèñê â ýòîé òåìå:

Ðàñøèðåííûé ïîèñê
Îïöèè ïðîñìîòðà

Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 19:35.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.